Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
$24,000
Est. net congressional buying / selling (2 years). Updated Sep 11, 2026

Are Members of Congress Buying or Selling Atricure?

1 member of the U.S. Congress has traded Atricure (ATRC) stock in the past 90 days, all purchases. Congressional trades are reported under the STOCK Act and are typically disclosed within 45 days of the transaction.

Congressional trading is one of the alternative data signals AltIndex tracks as part of the ATRC AI Score. For corporate insider activity, see ATRC insider transactions. To browse trades across every ticker, visit the Congress Trading tracker.

Which Congress Members Are Trading Atricure?

Member of CongressActivityTradesLast Trade
Gilbert Cisneros Bought $24,000 3 Aug 20, 2026

ATRC Congressional Trade History

Member of CongressTrade DateTypeEstimated Size
Gilbert Cisneros Aug 20, 2026 Buy $1K – $15K
Gilbert Cisneros Mar 3, 2026 Buy $1K – $15K
Gilbert Cisneros May 6, 2025 Buy $1K – $15K

Frequently Asked Questions: Atricure Congress Trading

In the past 90 days, members of Congress have made 1 purchase and 0 sales of ATRC stock. The net buying may reflect confidence in the stock. Congressional trades are disclosed under the STOCK Act — view the full history on this page.

Some research has found that congressional stock trades have at times outperformed the market, possibly due to informational advantages. AltIndex tracks these trades as one of 25+ signals in the AI Score. See the full Congress Trading tracker for all recent trades.

Gilbert Cisneros bought Atricure (ATRC) stock most recently, on August 20, 2026.

The estimated net value of congressional trades in Atricure over the past 2 years is positive, at $24,000, meaning members of Congress have on balance bought more than they have sold.

Members of Congress can have early visibility into legislation, regulation, and government contracts that may affect a company. Tracking their disclosed trades — alongside other signals — can offer additional context for investment decisions.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.